Ranbaxy Buyers' $485M Deal In Generics MDL Gets Initial Nod
By Madeline Lyskawa · April 29, 2022, 6:04 PM EDT
Ranbaxy Pharmaceuticals drug purchasers nabbed initial approval of a $485 million global settlement struck in March over claims the drugmaker manipulated the U.S. Food and Drug Administration's generic-drug approval process to...
To view the full article, register now.